Categories: Joint Venture

Metropolis Healthcare India Expands its Footprints to Mauritius


Hyderabad, October 21, 2014:
Metropolis Healthcare Ltd., The Pathology Specialist, today announced a joint venture with Bramser Corporation. The joint venture, Metropolis Brasmer Lab Services Mauritius Ltd will introduce pathology services of highest quality and global standards to the nation. To begin with Metropolis has one central laboratory with collection points across Mauritius, Madagascar, Seychelles & Reunion. The central laboratory is located on the premises of the Apollo Bramwell Hospital and pathology services will be available to patients in the hospital as well as the citizens of Mauritius.

Plans are to set up 25 collection points across these locations in the coming year, with a focus remaining on providing quality diagnostic facilities to this region. Metropolis Healthcare will be opening 5 collection points with immediate effect at Port Louis, Curepipe, Moka, Quatre Bornes & Rose-Hill, with 2 more laboratories coming up across Central Flacq & Black River in the next 3 months. Investments planned around the joint venture are in the region of 50 million Mauritian Rupees.

Speaking at the occasion of the joint venture, Ms. Ameera Shah, Managing Director & CEO said, “As India’s most respected chain of pathology laboratories, we are looking at 1000 tests being performed locally in Mauritius. We also have the advantage of offering 4500 tests with the best turnaround time. We would be the first and foremost in the Mauritius diagnostic industry to offer the widest test menu combined with the highest standard of quality at an affordable rate.”

Mr Claudio Feistritzer-Rawat, Director of Metropolis Bramser Lab Services Mauritius Ltd explained, “There is a growing need for quality diagnostics in Mauritius. Our understanding of the market, combined with Metropolis’ expertise in global healthcare diagnostics, we look to bridge that gap while ensuring affordability and quality.”

Close to 2000 kilometers of the coast of the Indian subcontinent, Mauritius was ranked 9th out of 183 economies recently by the World Bank on the parameter of ‘Ease of Doing Business’. One of the world’s top tourist destinations, Mauritius is crowded throughout the year, ensuring that at present strength, the country is underpowered as far as diagnostic facilities go. Metropolis Healthcare Ltd., with a presence in UAE, Sri Lanka, South Africa, Kenya and Ghana is thus an ideal fit to ensure that affordable quality diagnostics are available for and in the island nation. CCI Newswire

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

14 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

15 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

1 day ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

2 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago